Mabwell Biotech

About

Mabwell Biotech is a Chinese innovative biopharmaceutical company.

Shanghai,Shanghai,China
501 - 1000

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $278.50M
Industries: Biopharma,Biotechnology,Life Science
Founded date: Jan 1, 2017
Number Of Employee: 501 - 1000
Operating Status: Active
Legal Name: Mabwell (Shanghai) Bioscience Co., Ltd

Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$278.50M

Mabwell Biotech has raised a total of $278.50M in funding over 2 rounds. Their latest funding was raised on Apr 29, 2020 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Apr 29, 2020	Series A	$278.50M	9	Shiyu Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

9

Mabwell Biotech is funded by 9 investors. Shiyu Capital and Haitong Leading Capital Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Shiyu Capital	Yes	Series A
Haitong Leading Capital Management	—	Series A
Founder H Fund	—	Series A
Huajin Capital	—	Series A
Huarong Rongde Asset Management	—	Series A
Loyal Valley Capital	—	Series A
Oriental Fortune Capital	—	Series A
Sincere Capital	—	Series A
Winfast Holding	—	Series A